The case for eteplirsen: Paving the way for precision medicine

Mol Genet Metab. 2016 Jun;118(2):70-1. doi: 10.1016/j.ymgme.2016.04.001. Epub 2016 Apr 14.
No abstract available

MeSH terms

  • Administration, Intravenous
  • Child
  • Disease Progression
  • Dystrophin / genetics
  • Exons
  • Humans
  • Male
  • Morpholinos / genetics
  • Morpholinos / therapeutic use*
  • Muscular Dystrophy, Duchenne / genetics
  • Muscular Dystrophy, Duchenne / therapy*
  • Mutation
  • Open Reading Frames
  • Precision Medicine*
  • RNA, Messenger / genetics
  • Rare Diseases / genetics
  • Rare Diseases / therapy*
  • Treatment Outcome
  • United States
  • United States Food and Drug Administration

Substances

  • Dystrophin
  • Morpholinos
  • RNA, Messenger
  • eteplirsen